Charles River Laboratories International (CRL) Current Assets: 2009-2025
Historic Current Assets for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $1.5 billion.
- Charles River Laboratories International's Current Assets rose 2.50% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 2.50%. This contributed to the annual value of $1.4 billion for FY2024, which is 12.78% down from last year.
- Charles River Laboratories International's Current Assets amounted to $1.5 billion in Q3 2025, which was up 4.23% from $1.5 billion recorded in Q2 2025.
- Charles River Laboratories International's 5-year Current Assets high stood at $1.7 billion for Q1 2024, and its period low was $1.3 billion during Q2 2021.
- Over the past 3 years, Charles River Laboratories International's median Current Assets value was $1.5 billion (recorded in 2024), while the average stood at $1.5 billion.
- Its Current Assets has fluctuated over the past 5 years, first grew by 20.94% in 2021, then decreased by 12.78% in 2024.
- Quarterly analysis of 5 years shows Charles River Laboratories International's Current Assets stood at $1.3 billion in 2021, then grew by 12.95% to $1.4 billion in 2022, then grew by 11.79% to $1.6 billion in 2023, then decreased by 12.78% to $1.4 billion in 2024, then climbed by 2.50% to $1.5 billion in 2025.
- Its Current Assets was $1.5 billion in Q3 2025, compared to $1.5 billion in Q2 2025 and $1.5 billion in Q1 2025.